{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T04:29:08Z","timestamp":1771648148447,"version":"3.50.1"},"reference-count":52,"publisher":"Walter de Gruyter GmbH","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,1,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Mauriac syndrome is characterized by growth impairment, Cushingoid features, and hepatomegaly in patients with poorly controlled type 1 diabetes mellitus (T1DM). We report a novel presentation of Mauriac syndrome in a 9-year-old girl who was diagnosed with neonatal diabetes at 3 months of age due to the p.R201C mutation in<\/jats:p>","DOI":"10.1515\/jpem-2016-0065","type":"journal-article","created":{"date-parts":[[2016,7,18]],"date-time":"2016-07-18T08:14:58Z","timestamp":1468829698000},"source":"Crossref","is-referenced-by-count":4,"title":["A girl with permanent neonatal diabetes due to KCNJ11 mutation presented with Mauriac syndrome after improper adjustment in sulfonylurea dosage over 6 years"],"prefix":"10.1515","volume":"29","author":[{"given":"Rapeepun","family":"Chai-udom","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taninee","family":"Sahakitrungruang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suttipong","family":"Wacharasindhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vichit","family":"Supornsilchai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"374","reference":[{"key":"ref311","doi-asserted-by":"crossref","first-page":"63","DOI":"10.4158\/EP.13.1.63","article-title":"Mauriac syndrome in a 3-year-old boy","volume":"13","year":"2007","journal-title":"Endocr Pract"},{"key":"ref461","first-page":"895","article-title":"Familial permanent neonatal diabetes with KCNJ11 mutation and the response to glyburide therapy\u2013a three-year follow-up","volume":"21","year":"2008","journal-title":"J Pediatr Endocrinol Metab"},{"key":"ref111","doi-asserted-by":"crossref","first-page":"2736","DOI":"10.1007\/s00125-011-2273-7","article-title":"No beta cell desensitisation after a median of 68 months on glibenclamide therapy in patients with KCNJ11-associated permanent neonatal diabetes","volume":"54","year":"2011","journal-title":"Diabetologia"},{"key":"ref181","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1002\/(SICI)1096-9136(199804)15:4<297::AID-DIA572>3.0.CO;2-W","article-title":"UKPDS 26: Sulphonylurea failure in non-insulin-dependent diabetic patients over six years. UK Prospective Diabetes Study (UKPDS) Group","volume":"15","year":"1998","journal-title":"Diabet Med"},{"key":"ref351","first-page":"402","article-title":"Gros ventre, hepatomegalie, troubles de las croissance chez les enfants diabetiques traites depuis plesieus annes par l\u2019insuline","volume":"26","year":"1930","journal-title":"Gaz Hebd Sci Med Bordeaux"},{"key":"ref501","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S2213-8587(13)70059-7","article-title":"Neuropsychological dysfunction and developmental defects associated with genetic changes in infants with neonatal diabetes mellitus: a prospective cohort study [corrected]","volume":"1","year":"2013","journal-title":"Lancet Diabetes Endocrinol"},{"key":"ref271","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.endonu.2012.12.005","article-title":"Mauriac syndrome still exists","volume":"60","year":"2013","journal-title":"Endocrinol Nutr"},{"key":"ref361","article-title":"Bilateral cataracts in a 6-yr-old with new onset diabetes: a novel presentation of a known INS gene mutation","year":"2015","journal-title":"Pediatr Diabetes"},{"key":"ref481","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/s00431-008-0757-3","article-title":"Transition from insulin to sulfonylurea in a child with diabetes due to a mutation in KCNJ11 encoding Kir6.2 \u2013 initial and long-term response to sulfonylurea therapy","volume":"168","year":"2009","journal-title":"Eur J Pediatr"},{"key":"ref291","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.2337\/diacare.27.8.2094","article-title":"Improper insulin compliance may lead to hepatomegaly and elevated hepatic enzymes in type 1 diabetic patients: response to Yu and Howard","volume":"27","year":"2004","journal-title":"Diabetes care"},{"key":"ref391","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1056\/NEJMoa061759","article-title":"Neonatal Diabetes International Collaborative Group. Switching from insulin to oral sulfonylureas in patients with diabetes due to Kir6.2 mutations","volume":"355","year":"2006","journal-title":"N Engl J Med"},{"key":"ref71","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1016\/0026-0495(91)90138-M","article-title":"Function of the growth hormone-insulin-like growth factor I axis in the profoundly growth-retarded diabetic child: evidence for defective target organ responsiveness in the Mauriac syndrome","volume":"40","year":"1991","journal-title":"Metabolism"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S0168-8227(01)00298-4","article-title":"Mauriac syndrome still exists","volume":"54","year":"2001","journal-title":"Diabetes Res Clin Pract"},{"key":"ref451","doi-asserted-by":"crossref","first-page":"e206","DOI":"10.1371\/journal.pmed.0050206","article-title":"Chronic antidiabetic sulfonylureas in vivo: reversible effects on mouse pancreatic beta-cells","volume":"5","year":"2008","journal-title":"PLoS Med"},{"key":"ref301","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/S0022-3476(77)80452-6","article-title":"Stunted growth and hepatomegaly in diabetes mellitus","volume":"91","year":"1977","journal-title":"J Pediatr"},{"key":"ref421","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1007\/s00125-016-3921-8","article-title":"Successful transfer to sulfonylureas in KCNJ11 neonatal diabetes is determined by the mutation and duration of diabetes","volume":"59","year":"2016","journal-title":"Diabetologia"},{"key":"ref251","doi-asserted-by":"crossref","first-page":"2086","DOI":"10.2337\/dc11-2225","article-title":"Visuomotor performance in KCNJ11-related neonatal diabetes is impaired in children with DEND-associated mutations and may be improved by early treatment with sulfonylureas","volume":"35","year":"2012","journal-title":"Diabetes care"},{"key":"ref431","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1007\/s00125-015-3593-9","article-title":"Age at the time of sulfonylurea initiation influences treatment outcomes in KCNJ11-related neonatal diabetes","volume":"58","year":"2015","journal-title":"Diabetologia"},{"key":"ref101","article-title":"Bilateral cataracts in a 6-yr-old with new onset diabetes: a novel presentation of a known INS gene mutation","year":"2015","journal-title":"Pediatr Diabetes"},{"key":"ref201","first-page":"895","article-title":"Familial permanent neonatal diabetes with KCNJ11 mutation and the response to glyburide therapy\u2013a three-year follow-up","volume":"21","year":"2008","journal-title":"J Pediatr Endocrinol Metab"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"63","DOI":"10.4158\/EP.13.1.63","article-title":"Mauriac syndrome in a 3-year-old boy","volume":"13","year":"2007","journal-title":"Endocr Pract"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.endonu.2012.12.005","article-title":"Mauriac syndrome still exists","volume":"60","year":"2013","journal-title":"Endocrinol Nutr"},{"key":"ref261","doi-asserted-by":"crossref","first-page":"486","DOI":"10.4103\/2230-8210.95759","article-title":"A rare case of Mauriac syndrome","volume":"16","year":"2012","journal-title":"Indian J Endocrinol Metab"},{"key":"ref81","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1177\/000992287401300904","article-title":"The Mauriac syndrome","volume":"13","year":"1974","journal-title":"Clin Pediatr (Phila)"},{"key":"ref341","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1177\/000992287401300904","article-title":"The Mauriac syndrome","volume":"13","year":"1974","journal-title":"Clin Pediatr (Phila)"},{"key":"ref121","doi-asserted-by":"crossref","first-page":"2717","DOI":"10.1093\/hmg\/ddi305","article-title":"Functional effects of KCNJ11 mutations causing neonatal diabetes: enhanced activation by MgATP","volume":"14","year":"2005","journal-title":"Hum Mol Genet"},{"key":"ref511","doi-asserted-by":"crossref","first-page":"2086","DOI":"10.2337\/dc11-2225","article-title":"Visuomotor performance in KCNJ11-related neonatal diabetes is impaired in children with DEND-associated mutations and may be improved by early treatment with sulfonylureas","volume":"35","year":"2012","journal-title":"Diabetes care"},{"key":"ref411","doi-asserted-by":"crossref","first-page":"2210","DOI":"10.1007\/s00125-006-0329-x","article-title":"Sulfonylurea treatment outweighs insulin therapy in shortterm metabolic control of patients with permanent neonatal diabetes due to activating mutations of the KCNJ11 (Kir 6.2) gene","volume":"49","year":"2006","journal-title":"Diabetologia"},{"key":"ref151","doi-asserted-by":"crossref","first-page":"2210","DOI":"10.1007\/s00125-006-0329-x","article-title":"Sulfonylurea treatment outweighs insulin therapy in shortterm metabolic control of patients with permanent neonatal diabetes due to activating mutations of the KCNJ11 (Kir 6.2) gene","volume":"49","year":"2006","journal-title":"Diabetologia"},{"key":"ref191","doi-asserted-by":"crossref","first-page":"e206","DOI":"10.1371\/journal.pmed.0050206","article-title":"Chronic antidiabetic sulfonylureas in vivo: reversible effects on mouse pancreatic beta-cells","volume":"5","year":"2008","journal-title":"PLoS Med"},{"key":"ref491","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1590\/S0004-27302010000800003","article-title":"Long-term response to sulfonylurea in a patient with diabetes due to mutation in the KCNJ11 gene","volume":"54","year":"2010","journal-title":"Mois\u00e9s Arq Bras Endocrinol Metab"},{"key":"ref441","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1002\/(SICI)1096-9136(199804)15:4<297::AID-DIA572>3.0.CO;2-W","article-title":"UKPDS 26: Sulphonylurea failure in non-insulin-dependent diabetic patients over six years. UK Prospective Diabetes Study (UKPDS) Group","volume":"15","year":"1998","journal-title":"Diabet Med"},{"key":"ref01","doi-asserted-by":"crossref","first-page":"486","DOI":"10.4103\/2230-8210.95759","article-title":"A rare case of Mauriac syndrome","volume":"16","year":"2012","journal-title":"Indian J Endocrinol Metab"},{"key":"ref281","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S0168-8227(01)00298-4","article-title":"Mauriac syndrome still exists","volume":"54","year":"2001","journal-title":"Diabetes Res Clin Pract"},{"key":"ref381","doi-asserted-by":"crossref","first-page":"2717","DOI":"10.1093\/hmg\/ddi305","article-title":"Functional effects of KCNJ11 mutations causing neonatal diabetes: enhanced activation by MgATP","volume":"14","year":"2005","journal-title":"Hum Mol Genet"},{"key":"ref401","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1210\/jc.2006-2490","article-title":"Prevalence of permanent neonatal diabetes in Slovakia and successful replacement of insulin with sulfonylurea therapy in KCNJ11 and ABCC8 mutation carriers","volume":"92","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"ref161","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1007\/s00125-016-3921-8","article-title":"Successful transfer to sulfonylureas in KCNJ11 neonatal diabetes is determined by the mutation and duration of diabetes","volume":"59","year":"2016","journal-title":"Diabetologia"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.2337\/diacare.27.8.2094","article-title":"Improper insulin compliance may lead to hepatomegaly and elevated hepatic enzymes in type 1 diabetic patients: response to Yu and Howard","volume":"27","year":"2004","journal-title":"Diabetes care"},{"key":"ref471","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1089\/dia.2009.0165","article-title":"Efficacy and safety of sulfonylurea use in permanent neonatal diabetes due to KCNJ11 gene mutations: 34-month median follow-up","volume":"12","year":"2010","journal-title":"Diabetes Technol Ther"},{"key":"ref371","doi-asserted-by":"crossref","first-page":"2736","DOI":"10.1007\/s00125-011-2273-7","article-title":"No beta cell desensitisation after a median of 68 months on glibenclamide therapy in patients with KCNJ11-associated permanent neonatal diabetes","volume":"54","year":"2011","journal-title":"Diabetologia"},{"key":"ref91","first-page":"402","article-title":"Gros ventre, hepatomegalie, troubles de las croissance chez les enfants diabetiques traites depuis plesieus annes par l\u2019insuline","volume":"26","year":"1930","journal-title":"Gaz Hebd Sci Med Bordeaux"},{"key":"ref141","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1210\/jc.2006-2490","article-title":"Prevalence of permanent neonatal diabetes in Slovakia and successful replacement of insulin with sulfonylurea therapy in KCNJ11 and ABCC8 mutation carriers","volume":"92","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/S0022-3476(77)80452-6","article-title":"Stunted growth and hepatomegaly in diabetes mellitus","volume":"91","year":"1977","journal-title":"J Pediatr"},{"key":"ref241","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S2213-8587(13)70059-7","article-title":"Neuropsychological dysfunction and developmental defects associated with genetic changes in infants with neonatal diabetes mellitus: a prospective cohort study [corrected]","volume":"1","year":"2013","journal-title":"Lancet Diabetes Endocrinol"},{"key":"ref221","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/s00431-008-0757-3","article-title":"Transition from insulin to sulfonylurea in a child with diabetes due to a mutation in KCNJ11 encoding Kir6.2 \u2013 initial and long-term response to sulfonylurea therapy","volume":"168","year":"2009","journal-title":"Eur J Pediatr"},{"key":"ref61","first-page":"900","article-title":"The Mauriac syndrome","volume":"127","year":"1974","journal-title":"Am J Dis Child"},{"key":"ref131","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1056\/NEJMoa061759","article-title":"Neonatal Diabetes International Collaborative Group. Switching from insulin to oral sulfonylureas in patients with diabetes due to Kir6.2 mutations","volume":"355","year":"2006","journal-title":"N Engl J Med"},{"key":"ref171","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1007\/s00125-015-3593-9","article-title":"Age at the time of sulfonylurea initiation influences treatment outcomes in KCNJ11-related neonatal diabetes","volume":"58","year":"2015","journal-title":"Diabetologia"},{"key":"ref211","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1089\/dia.2009.0165","article-title":"Efficacy and safety of sulfonylurea use in permanent neonatal diabetes due to KCNJ11 gene mutations: 34-month median follow-up","volume":"12","year":"2010","journal-title":"Diabetes Technol Ther"},{"key":"ref231","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1590\/S0004-27302010000800003","article-title":"Long-term response to sulfonylurea in a patient with diabetes due to mutation in the KCNJ11 gene","volume":"54","year":"2010","journal-title":"Mois\u00e9s Arq Bras Endocrinol Metab"},{"key":"ref321","first-page":"900","article-title":"The Mauriac syndrome","volume":"127","year":"1974","journal-title":"Am J Dis Child"},{"key":"ref331","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1016\/0026-0495(91)90138-M","article-title":"Function of the growth hormone-insulin-like growth factor I axis in the profoundly growth-retarded diabetic child: evidence for defective target organ responsiveness in the Mauriac syndrome","volume":"40","year":"1991","journal-title":"Metabolism"}],"container-title":["Journal of Pediatric Endocrinology and Metabolism"],"original-title":[],"link":[{"URL":"http:\/\/www.degruyter.com\/view\/j\/jpem.2016.29.issue-9\/jpem-2016-0065\/jpem-2016-0065.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.degruyter.com\/document\/doi\/10.1515\/jpem-2016-0065\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,22]],"date-time":"2021-04-22T01:40:43Z","timestamp":1619055643000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.degruyter.com\/document\/doi\/10.1515\/jpem-2016-0065\/html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1,1]]},"references-count":52,"journal-issue":{"issue":"9"},"URL":"https:\/\/doi.org\/10.1515\/jpem-2016-0065","relation":{},"ISSN":["2191-0251","0334-018X"],"issn-type":[{"value":"2191-0251","type":"electronic"},{"value":"0334-018X","type":"print"}],"subject":[],"published":{"date-parts":[[2016,1,1]]}}}